miR-410-5p promotes the development of diabetic cardiomyopathy by suppressing PIM1-induced anti-apoptosis.

Explore this paper's citation graph

Summary

It is demonstrated that miR-410-5p might be involved in the progression of DCM by targeting PIM1 and might be a promising therapeutic target for DCM in the future.

Type
article
Published
2020-03-04
Cited by
19
References
35

Keywords

Diabetic cardiomyopathy, PIM1, Biology, Diabetes mellitus, Gene knockdown

References

Cited by

Related papers